Vera Therapeutics (VERA) Shareholder's Equity Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.60% |
| Dec 31, 2025 | 4.74% |
| Sep 30, 2025 | 37.99% |
| Jun 30, 2025 | 42.82% |
| Mar 31, 2025 | 51.33% |
| Dec 31, 2024 | 467.59% |
| Sep 30, 2024 | 133.66% |
| Jun 30, 2024 | 133.32% |
| Mar 31, 2024 | 124.17% |
| Dec 31, 2023 | 32.22% |
| Sep 30, 2023 | 17.02% |
| Jun 30, 2023 | 15.65% |
| Mar 31, 2023 | 17.32% |
| Dec 31, 2022 | 10.51% |
| Sep 30, 2022 | 23.68% |
| Jun 30, 2022 | 31.85% |
| Mar 31, 2022 | 244.05% |
| Dec 31, 2021 | 177.89% |
| Sep 30, 2021 | 282.35% |
| Jun 30, 2021 | 316.98% |
| Mar 31, 2021 | -139.60% |